Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
World J Surg Oncol. 2012 Jun 26;10:118. doi: 10.1186/1477-7819-10-118.

Outcome analysis of breast cancer patients who declined evidence-based treatment.

Author information

  • 1Division of Radiation Oncology, University of Alberta, Edmonton, AB, Canada. kurian.joseph@albertahealthservices.ca

Abstract

BACKGROUND:

To analyze the characteristics and outcomes of women with breast cancer in the Northern Alberta Health Region (NAHR) who declined recommended primary standard treatments.

METHODS:

A chart review was performed of breast cancer patients who refused recommended treatments during the period 1980 to 2006. A matched pair analysis was performed to compare the survival data between those who refused or received standard treatments.

RESULTS:

A total of 185 (1.2%) patients refused standard treatment. Eighty-seven (47%) were below the age of 75 at diagnosis. The majority of those who refused standard treatments were married (50.6%), 50 years or older (60.9%), and from the urban area (65.5%). The 5-year overall survival rates were 43.2% (95% CI: 32.0 to 54.4%) for those who refused standard treatments and 81.9% (95% CI: 76.9 to 86.9%) for those who received them. The corresponding values for the disease-specific survival were 46.2% (95% CI: 34.9 to 57.6%) vs. 84.7% (95% CI: 80.0 to 89.4%).

CONCLUSIONS:

Women who declined primary standard treatment had significantly worse survival than those who received standard treatments. There is no evidence to support using Complementary and Alternative Medicine (CAM) as primary cancer treatment.

PMID:
22734852
[PubMed - indexed for MEDLINE]
PMCID:
PMC3438047
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk